Youtube
search
IT
EN
Home
About us
Activities
Testing
Procedures
Biological Passport Program
Annual Reports
Covid-19 Guidelines
Education
Education Program
Education Pool
E-learning Courses
Events
Publications and References
Therapeutic Use Exemptions
TUE Submission Procedure
TUE Application Form
Checklist
WADA Guidelines
Results Management
Definition
Procedure
Speak Up
Consequences of Doping
Prohibited Association
Athletes
Rights and Responsibilities
The Principle of Strict Liability
Athletes' Antidoping Rights Act WADA
Processing of personal data
Antidoping Ombuds
The Prohibited List
Wada List
RTP
Inclusion Criteria
RTP List
Whereabouts
Forms and Manuals
TUE
TUE Submission Procedure
TUE Application Form
Anti-Doping Rules
National
Anti-doping Sport Rules
Anti-doping State Rules
International
Wada Code
International Standards
Conventions
News
Antidoping Rule Violations (ADRVs)
News and Announcements
FAQ
Contacts
Home
Activities
Therapeutic Use Exemptions
WADA Guidelines
WADA Guidelines - Medical Information
GLUCOCORTICOIDS
Published on 26 November 2021
ADHD
Published on 20 September 2021
ADRENAL INSUFFICIENCY
Published on 20 September 2021
ANAPHYLAXIS
Published on 20 September 2021
ASTHMA
Published on 20 September 2021
CARDIOVASCULAR CONDITIONS /USE OF BETA-BLOCKERS
Published on 20 September 2021
GH – ADULT
Published on 20 September 2021
DIABETES MELLITUS
Published on 20 September 2021
INFERTILITY
Published on 20 September 2021
GH – CHILD
Published on 20 September 2021
INFLAMMATORY BOWEL DISEASE
Published on 20 September 2021
INTRAVENOUS INFUSIONS AND/OR INJECTIONS
Published on 20 September 2021
MALE HYPOGONADISM
Published on 20 September 2021
INTRINSIC SLEEP DISORDERS
Published on 20 September 2021
MUSCULOSKELETAL CONDITIONS
Published on 20 September 2021
NEUROPATHIC PAIN
Published on 20 September 2021
RENAL TRANSPLANTATION
Published on 20 September 2021
SINUSITIS/RHINOSINUSITIS
Published on 20 September 2021
TRANSGENDER ATHLETES
Published on 20 September 2021
